Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease.
about
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study
P2860
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Decreased body mass index in t ...... dominant Alzheimer's disease.
@ast
Decreased body mass index in t ...... dominant Alzheimer's disease.
@en
type
label
Decreased body mass index in t ...... dominant Alzheimer's disease.
@ast
Decreased body mass index in t ...... dominant Alzheimer's disease.
@en
prefLabel
Decreased body mass index in t ...... dominant Alzheimer's disease.
@ast
Decreased body mass index in t ...... dominant Alzheimer's disease.
@en
P2093
P2860
P50
P1433
P1476
Decreased body mass index in t ...... dominant Alzheimer's disease.
@en
P2093
Bernardino Ghetti
Chengjie Xiong
Christoph Laske
Douglas Galasko
Eric McDade
Janko Dietzsch
John M Ringman
Kimberly A Quaid
Neill R Graff-Radford
Oliver Preische
P2860
P2888
P356
10.1038/S41598-017-01327-W
P407
P50
P577
2017-04-27T00:00:00Z
P6179
1085072529